GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 794 filers reported holding GLAXOSMITHKLINE PLC in Q4 2018. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $6,000 | 0.0% | 145 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $6,000 | +20.0% | 145 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $5,000 | -95.1% | 145 | -94.8% | 0.00% | -96.0% |
| Q4 2020 | $102,000 | +13.3% | 2,795 | +16.7% | 0.02% | 0.0% |
| Q3 2020 | $90,000 | -40.4% | 2,395 | -35.2% | 0.02% | -44.4% |
| Q2 2020 | $151,000 | +7.9% | 3,695 | 0.0% | 0.04% | -11.8% |
| Q1 2020 | $140,000 | -25.5% | 3,695 | -7.6% | 0.05% | -7.3% |
| Q4 2019 | $188,000 | +5.6% | 4,000 | -4.3% | 0.06% | -1.8% |
| Q3 2019 | $178,000 | +6.6% | 4,180 | 0.0% | 0.06% | +7.7% |
| Q2 2019 | $167,000 | -6.7% | 4,180 | -2.3% | 0.05% | -8.8% |
| Q1 2019 | $179,000 | +105.7% | 4,280 | +88.1% | 0.06% | +78.1% |
| Q4 2018 | $87,000 | 0.0% | 2,275 | +4.6% | 0.03% | +18.5% |
| Q3 2018 | $87,000 | -33.1% | 2,175 | -32.6% | 0.03% | -37.2% |
| Q2 2018 | $130,000 | +1.6% | 3,225 | -1.5% | 0.04% | 0.0% |
| Q1 2018 | $128,000 | +10.3% | 3,275 | 0.0% | 0.04% | +16.2% |
| Q4 2017 | $116,000 | -73.2% | 3,275 | -69.3% | 0.04% | -74.1% |
| Q3 2017 | $433,000 | -5.9% | 10,670 | 0.0% | 0.14% | -7.1% |
| Q2 2017 | $460,000 | +2.4% | 10,670 | 0.0% | 0.15% | +2.0% |
| Q1 2017 | $449,000 | +9.5% | 10,670 | 0.0% | 0.15% | +2.7% |
| Q4 2016 | $410,000 | -4.7% | 10,670 | +7.0% | 0.15% | -5.8% |
| Q3 2016 | $430,000 | +46.8% | 9,970 | +47.3% | 0.16% | +44.4% |
| Q2 2016 | $293,000 | +2.4% | 6,770 | -3.9% | 0.11% | 0.0% |
| Q1 2016 | $286,000 | +13.9% | 7,043 | +13.2% | 0.11% | +9.1% |
| Q4 2015 | $251,000 | +7.3% | 6,220 | +2.4% | 0.10% | +8.8% |
| Q3 2015 | $234,000 | -6.0% | 6,075 | +1.7% | 0.09% | +2.2% |
| Q2 2015 | $249,000 | -9.8% | 5,975 | 0.0% | 0.09% | -9.2% |
| Q1 2015 | $276,000 | +7.8% | 5,975 | 0.0% | 0.10% | +5.4% |
| Q4 2014 | $256,000 | -5.5% | 5,975 | +1.4% | 0.09% | -15.5% |
| Q3 2014 | $271,000 | -18.1% | 5,890 | -4.8% | 0.11% | -14.7% |
| Q2 2014 | $331,000 | -1.5% | 6,190 | -1.6% | 0.13% | -5.1% |
| Q1 2014 | $336,000 | -1.8% | 6,290 | -1.8% | 0.14% | -4.2% |
| Q4 2013 | $342,000 | +6.5% | 6,404 | 0.0% | 0.14% | -1.4% |
| Q3 2013 | $321,000 | +29.4% | 6,404 | +29.0% | 0.14% | +20.0% |
| Q2 2013 | $248,000 | – | 4,964 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |